11814389001
Roche
Red Blood Cell Lysis Buffer
solution, Roche, pkg of 100 mL, sufficient for 50-500 reactions
Sinonimo/i:
RBC Lysis Buffer, lysis buffer, red blood cells
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Codice UNSPSC:
23201100
Prodotti consigliati
Stato
solution
impiego
sufficient for 50-500 reactions
Confezionamento
pkg of 100 mL
Produttore/marchio commerciale
Roche
Temperatura di conservazione
2-8°C
Categorie correlate
Descrizione generale
Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for further applications. This buffer is not intended for use with whole blood from any other species.
Applicazioni
Red blood cell lysis buffer has been used in the isolation of PBMCs (peripheral blood mononuclear cells) from HIV infected patients. It has also been used in the isolation of lung cellsm, naive CD8+ T cells and infected cells from the lung.
Used for both DNA and RNA isolation, the buffer is designed for the preferential lysis of red blood cells from human whole blood, yielding intact white blood cells (free of red blood cells) for use in further research applications.
It has been used for the lysis of blood cells in femoral bone marrow, PBMC (peripheral blood mononuclear cells) and human lung adenocarcinoma samples.
It has been used for the lysis of blood cells in femoral bone marrow, PBMC (peripheral blood mononuclear cells) and human lung adenocarcinoma samples.
Stato fisico
Ready-to-use solution.
Altre note
For life science research only. Not for use in diagnostic procedures.
Classe di pericolosità dell'acqua (WGK)
nwg
Punto d’infiammabilità (°F)
No data available
Punto d’infiammabilità (°C)
No data available
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
I clienti hanno visto anche
Jeroen J A van Kampen et al.
PloS one, 5(7), e11409-e11409 (2010-07-14)
HIV protease inhibitors must penetrate into cells to exert their action. Differences in the intracellular pharmacokinetics of these drugs may explain why some patients fail on therapy or suffer from drug toxicity. Yet, there is no information available on the
Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry
Van Kampen JJ, et al.
PLoS ONE, 5(7), 11409-11409 (2010)
A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles
Ramirez A, et al.
Vaccine (2018)
Methylthioadenosine (MTA) Rescues Methylthioadenosine Phosphorylase (MTAP)-deficient tumors from purine synthesis inhibition in vivo via non-autonomous adenine supply.
Ruefli-Brasse A
Journal of Cancer Therapy (2011)
Quantification of membrane transporter proteins in human lung and immortalized cell lines using targeted quantitative proteomic analysis by isotope dilution nanoLC?MS/MS
Fallon JK, et al.
Journal of Pharmaceutical and Biomedical Analysis, 154, 150-157 (2018)
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.